Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects
Clinical trial NCT04321252 · COMPLETED
Trial details
- NCT number
- NCT04321252
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-22
- Primary completion
- 2020-11-10
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.